The Asia Pacific pulmonary function testing systems market was valued at US$ 58.00 million in 2022 and is expected to reach US$ 87.40 million by 2028; it is estimated to register a CAGR of 7.1% from 2022 to 2028.
Home Healthcare Pulmonary Function Testing Systems to Provide Lucrative Opportunity for Asia Pacific Pulmonary Function Testing Systems Market Growth in Coming Years
The majority of lung function tests require specialized equipment that is only available in medical settings. However, at-home spirometers are available for patients suffering from lung disease. New approaches have enabled at-home spirometry to be performed with the assistance of a tablet or smartphone. Various leading companies are launching innovative medical products, particularly to perform sophisticated lung assessments at patients' homes. Moreover, EasyOne Pro provides accurate results through reliable ultrasound technology by eliminating calibration and maintenance costs. Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) testing can determine shortness of breath caused due to respiratory or cardiac disease and differentiate between asthma and chronic obstructive pulmonary disorder (COPD) for appropriate treatment. Therefore, commercializing home healthcare pulmonary function testing systems products is likely to offer lucrative opportunities for the growth of the Asia Pacific pulmonary function testing systems market in the coming years.
Asia Pacific Pulmonary Function Testing Systems Market Overview
The pulmonary function testing systems market growth in Asia Pacific countries is attributed to growing awareness regarding the usage of pulmonary function tests and a high emphasis on enhancing hospital infrastructure. Moreover, the presence of top competitive players in developing countries of Asia Pacific is expected to propel the overall market growth during the forecast period.
Asia Pacific Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Pulmonary Function Testing Systems Market Segmentation
The Asia Pacific pulmonary function testing systems market is segmented on the basis of type, test type, component, application, end user, and country.
Based on type, the Asia Pacific pulmonary function testing systems market is bifurcated into cart-based PFT systems and stationery PFT systems. The cart-based PFT systems segment held a larger share of the Asia Pacific pulmonary function testing systems market in 2022.
Based on test type, the Asia Pacific pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held the largest share of the Asia Pacific pulmonary function testing systems market in 2022.
Based on component, the Asia Pacific pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held the largest share of the Asia Pacific pulmonary function testing systems market in 2022.
Based on application, the Asia Pacific pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held the largest share of the Asia Pacific pulmonary function testing systems market in 2022.
Based on end-user, the Asia Pacific pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held the largest share of the Asia Pacific pulmonary function testing systems market in 2022.
Based on country, the Asia Pacific pulmonary function testing systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific pulmonary function testing systems market in 2022.
COSMED Srl, KoKo PFT Ltd, MGC Diagnostics Corp, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, Schiller AG, and Vyaire Medical Inc are the leading companies operating in the Asia Pacific pulmonary function testing systems market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 58.00 Million |
| Market Size by 2028 | US$ 87.40 Million |
| CAGR (2022 - 2028) | 7.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Pulmonary Function Testing Systems Market is valued at US$ 58.00 Million in 2022, it is projected to reach US$ 87.40 Million by 2028.
As per our report Asia Pacific Pulmonary Function Testing Systems Market, the market size is valued at US$ 58.00 Million in 2022, projecting it to reach US$ 87.40 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The Asia Pacific Pulmonary Function Testing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pulmonary Function Testing Systems Market report:
The Asia Pacific Pulmonary Function Testing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Pulmonary Function Testing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Pulmonary Function Testing Systems Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Pulmonary Function Testing Systems Market
